During a Q&A interview with ROI-NJ’s Brett Johnson, New Jersey Innovation Institute (NJII) President, Michael Johnson, breaks down the organization’s mission, how it’s accelerating innovation in New Jersey, some of the company’s recent wins, and more.
“Most people in New Jersey don’t know what NJII is or what the purpose of it even is. They also don’t know how large it is,” said Johnson. “It’s a beautiful hybrid entity that’s a conduit between the outside world and NJIT that’s the best of both worlds”.
Johnson also expands on his vision for the future of NJII, possible new divisions, and how his plans are inspired by the organization’s 2022 sale of its subsidiary CDMO, BioCentriq, for $73 million.
“We’re trying to find what divisions could allow us to build on what’s going on at NJIT while also looking to go after areas that are evolving and growing rapidly that are well positioned for success,” he said.
Read the full conversation here.